Ventilator Ventilator-Associated Associated Pneumonia Pneumonia ...

More documents

Recommendations

Info

First AuthorYearSensitivity95% CITejerina20100.600.50-0.69Pellosi20081.000.86-1.00Pham20070.770.46-0.95Veinstein20060.540.37-0.71Fartoukh20030.490.32-0.65Fábregas19990.420.15-0.72Carolina20040.770.59-0.90Luyt20040.490.37-0.57Jung20100.610.39-0.80Ramirez20080.800.63-0.92Croce20060.430.33-0.54Luyt20080.750.53-0.90Flanagan20000.910.84-0.95Pooled sensitivity = 0.64 (0.60 to 0.67)Chi 2 = 114.41; df = 12 (p
First AuthorYearSensitivity95% CITejerina20101.250.76-2.07Pellosi20081094.3342.74-28019.31Pham20071.670.31-8.93Veinstein20062.290.91-5.79Fartoukh20035.381.84-15.71Fábregas19992.380.42-13/39Carolina20042.400.91-8.33Luyt20046.893.24-14.66Jung20109.022.54-31.99Ramirez200814.002.37-82.72Croce20061.180.62-2.25Luyt20084.291.13-16.31Flanagan200055.9315.35-191.33Random Effects ModelPooled diagnostic odds ratio = 4.85(2.42 to 9.71)Cochran-Q = 67.85; df = 12 (p
Page 4: VAP Rates in the USA10.03000Mean VA
Page 8 and 9: Diagnostic Accuracy of CPIS: A Meta
Page 12 and 13: Diagnosing VAP in Critically Ill Pa
Page 14: Prognostic Value in VAP1.00.8Sensit
Page 17 and 18: Quantitative vs. qualitative cultur
Page 19 and 20: Common Causes of VAP - Bronchoscopi
Page 21 and 22: Risk Factors for MDR Pathogens Anti
Page 23 and 24: 10093.3908076.5Mortality (%)7060504
Page 25 and 26: 1.00.8Mild riskSurvival0.60.4High r
Page 27 and 28: The VAP PIRO ScorePIROcomorbidities
Page 29 and 30: Short course vs. Prolonged Antibiot
Page 31 and 32: Screened patients after daily round
Page 33 and 34: 1.00.9No treatmentSurvival0.80.70.6
Page 35 and 36: Pharmacologic-based Strategies for
Page 37 and 38: 186 citations14 potentiallyeligible
Page 39: Specific Quality improvement interv

Ventilator Ventilator-Associated Associated Pneumonia Pneumonia ...

Create successful ePaper yourself

Delete template?

Save as template?